Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07668882 · ClinicalTrials.gov registry record · NA
Noninvasive Thalamocortical Neuromodulation With Low-Intensity Focused Ultrasound for Persistent Developmental Stuttering
A NA study, sponsored by University of Michigan.
- Not yet
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT07668882 is a NA study that has not yet begun recruiting, run by University of Michigan. The registered enrollment target is 20 participants.
The verdict
NCT07668882, a NA study, has not yet begun recruiting, sponsored by University of Michigan.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This research is studying the use of low-intensity focused ultrasound (LIFU; a mild, noninvasive acoustic stimulation technique) in a small number of people to learn about its safety as a treatment for stuttering. LIFU is a small, safe sound signal that produces a gentle, pulsing flow of acoustic waves to help different parts of the brain communicate with each other. Researchers want to understand how the mild, non-invasive brain stimulation affects speech relevant brain areas, which may in turn affect speech fluency and speaking-related brain activity in people who stutter.
Interventions
- DEVICE Sham
- DEVICE High DC LIFU
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-06 |
| Est. Completion | 2027-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07668882
The ClinicalTrials.gov registry entry for NCT07668882 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham is the first listed.
NCT07668882 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07668882 about?
NCT07668882 is a clinical study titled "Noninvasive Thalamocortical Neuromodulation With Low-Intensity Focused Ultrasound for Persistent Developmental Stuttering". This research is studying the use of low-intensity focused ultrasound (LIFU; a mild, noninvasive acoustic stimulation technique) in a small number of people to learn about its safety as a treatment for stuttering. LIFU is a small, safe sound signal that produces a gentle, pulsing flow of acoustic wa...
What is the current status of trial NCT07668882?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-06. Estimated completion is 2027-06.
What interventions are being tested in trial NCT07668882?
The interventions under investigation include: Sham (DEVICE), High DC LIFU (DEVICE).
Who is sponsoring clinical trial NCT07668882?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.